PROJECT

Thanks to the unique organization of sarcoma care in France, the national database, the dynamism of the French Sarcoma Group and the capacity of their key opinion leaders to establish collaborations with pharma, the CONDOR partners are the most advanced in the field of sarcoma immunotherapy with the largest portfolio of immunotherapy trials worldwide. In this regard, CONDOR is unique by its capacity to leverage all the biological resources, and the patient recruitment potential needed to deliver its outputs.

We will develop 4 main deliverables:

I

A sarcoma immune atlas
(Characterization of sarcoma microenvironment)

II

Predictive digital
pathology tool

III

Predictive peripheral
plasma based signature

IV

Early phase trials
with new targets

PROJECT KEYS